← Back to Search

Vitamin

NR plus Walking Exercise for High Blood Pressure

Phase 1
Waitlist Available
Led By Robert Mankowski, PhD
Research Sponsored by University of Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline; week 3; week 6
Awards & highlights

Study Summary

This trial suggests that nicotinamide riboside may help hypertensive older adults by enhancing the effects of exercise therapy.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline; week 3; week 6
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline; week 3; week 6 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in SBP
Secondary outcome measures
Arterial Stiffness

Trial Design

3Treatment groups
Active Control
Group I: NR plus Walking ExerciseActive Control2 Interventions
1,000 mg/day of NR combined with three days/week of supervised, center-based walking exercise (n=18)
Group II: NR AloneActive Control1 Intervention
1,000 mg/day of NR
Group III: Walking Exercise plus PlaceboActive Control1 Intervention
1,000 mg/day of Placebo combined with three days/week of supervised, center-based walking exercise (n=18)

Find a Location

Who is running the clinical trial?

National Institute on Aging (NIA)NIH
1,692 Previous Clinical Trials
28,027,165 Total Patients Enrolled
University of FloridaLead Sponsor
1,350 Previous Clinical Trials
719,911 Total Patients Enrolled
Robert Mankowski, PhDPrincipal InvestigatorUniversity of Florida
1 Previous Clinical Trials
40 Total Patients Enrolled
~10 spots leftby May 2025